Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation.
Giordano A, Corcione N, Ferraro P, Morello A, Conte S, Testa L, Bedogni F, Iadanza A, Berti S, Regazzoli D, Romagnoli E, Trani C, Burzotta F, Pepe M, Frati G, Biondi-Zoccai G; Registro Italiano GISE sull’impianto di Valvola Aortica Percutanea (RISPEVA) Study Investigators. Giordano A, et al. Among authors: pepe m. Sci Rep. 2019 Nov 19;9(1):17098. doi: 10.1038/s41598-019-53081-w. Sci Rep. 2019. PMID: 31745198 Free PMC article.
Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices.
Giordano A, Corcione N, Ferraro P, Morello A, Conte S, Bedogni F, Testa L, Iadanza A, Sardella G, Mancone M, Tomai F, De Persio G, Attisano T, Pepe M, Frati G, Biondi-Zoccai G; RISPEVA (Registro Italiano GISE sull'impianto di Valvola Aortica Percutanea) Study Investigators. Giordano A, et al. Among authors: pepe m. Cardiovasc Revasc Med. 2019 Dec;20(12):1096-1099. doi: 10.1016/j.carrev.2019.01.017. Epub 2019 Jan 23. Cardiovasc Revasc Med. 2019. PMID: 30711476
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions.
Pepe M, Biondi-Zoccai G, Corcione N, Nestola PL, Ferraro P, Morello A, Conte S, Prati F, Bianchi FP, Bortone AS, Giordano A. Pepe M, et al. Am J Cardiol. 2019 Jul 15;124(2):195-204. doi: 10.1016/j.amjcard.2019.04.015. Epub 2019 Apr 23. Am J Cardiol. 2019. PMID: 31103132
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry).
Pepe M, Sardella G, Stefanini GG, Corcione N, Nestola PL, Morello A, Briguori C, Tamburino C, Fabbiocchi F, Rotolo FL, Tomai F, Paggi A, Lombardi M, Gioffrè G, Sclafani R, Rolandi A, Sciahbasi A, Scardaci F, Signore N, Mancone M, Giordano A. Pepe M, et al. Am J Cardiol. 2019 Nov 15;124(10):1518-1527. doi: 10.1016/j.amjcard.2019.08.015. Epub 2019 Aug 23. Am J Cardiol. 2019. PMID: 31547997
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation.
Giordano A, Corcione N, Ferraro P, Morello A, Conte S, Testa L, Iadanza A, Sardella G, Mancone M, Berti S, Petronio AS, Romagnoli E, Pepe M, Frati G, Biondi-Zoccai G; Registro Italiano GISE sull'impianto di Valvola Aortica Percutanea (RISPEVA) Study Investigators. Giordano A, et al. Among authors: pepe m. Minerva Cardioangiol. 2019 Dec;67(6):443-449. doi: 10.23736/S0026-4725.19.05071-0. Epub 2019 Oct 25. Minerva Cardioangiol. 2019. PMID: 31670491
596 results